Two wins with one scan? Australia’s Lung Cancer Screening Program is primed to spot CV disease risk
Low-dose CT scans can also pick up the radiological biomarker for coronary artery calcification.
As Australia approaches the launch of the ambitious National Lung Cancer Screening Program, experts say it could also identify the risk of cardiovascular diseases among those taking part.
The reason is straightforward.
Low-dose CT scans used to screen for lung cancer can also pick up the radiological biomarker for coronary artery calcification (CAC).
Dr Tracy Leong, respiratory and sleep medicine specialist from Austin Health, refers to a prospective observational study, including participants enrolled at a single Australian site of the International Lung Screen Trial, which found that 55% had incidental CAC without a prior history of coronary artery disease.
